.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Citi
Medtronic
Merck
QuintilesIMS
Baxter
Colorcon
UBS
Deloitte
Cantor Fitzgerald

Generated: June 26, 2017

DrugPatentWatch Database Preview

PENTOXIFYLLINE Drug Profile

« Back to Dashboard

What is the patent landscape for Pentoxifylline, and when can generic versions of Pentoxifylline launch?

Pentoxifylline is a drug marketed by Watson Labs, Mylan, Valeant Pharms, Pliva, Heritage Pharms Inc, Actavis Elizabeth, Apotex, Impax Labs, and Teva. and is included in nine NDAs.

The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.

Summary for Tradename: PENTOXIFYLLINE

Patents:0
Applicants:9
NDAs:9
Suppliers / Packagers: see list21
Bulk Api Vendors: see list57
Clinical Trials: see list86
Patent Applications: see list4,319
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PENTOXIFYLLINE at DailyMed

Pharmacology for Tradename: PENTOXIFYLLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL075107-001Sep 4, 1998DISCNNoNo► Subscribe► Subscribe
Apotex
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL075191-001Jun 9, 1999ABRXNoYes► Subscribe► Subscribe
Pliva
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL074874-001May 25, 1999DISCNNoNo► Subscribe► Subscribe
Impax Labs
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL075093-001Aug 10, 1999DISCNNoNo► Subscribe► Subscribe
Mylan
PENTOXIFYLLINE
pentoxifylline
TABLET, EXTENDED RELEASE;ORAL074425-001Jul 8, 1997ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Federal Trade Commission
McKesson
UBS
Covington
Julphar
Healthtrust
Farmers Insurance
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot